THE USE OF FARGALS AND BIOCEPS IN THE COMPLEX TREATMENT OF OSTEOMYELITIS OF THE MAXILLOFACIAL REGION

Abstract

In the complex treatment of 90 patients with osteomyelitis, we used the new drugs domestic FarGALS and Biocep for the first time. Clinical, laboratory and bacteriological efficacy assessments have shown that when using FarGALS and Bakstimsa preparations in the complex treatment of osteomyelitis, local and general signs of inflammation were eliminated much faster, wound cleansing from necrotic masses was accelerated, and wound healing by secondary tension was accelerated.